Brief: Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing
BRIEF-Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing July 24 (Reuters) - Lisata Therapeutics Inc LSTA.O:
LISATA THERAPEUTICS - TERMINATES MERGER AGREEMENT WITH KUVA LABS ON JULY 24, 2026 - SEC FILING
LISATA THERAPEUTICS - TERMINATION DUE TO KUVA LABS' FAILURE TO OBTAIN FINANCING AND ACCEPT TENDERED SHARES - SEC FILING
LISATA THERAPEUTICS - BOARD TO ASSESS STRATEGIC OPTIONS INCLUDING REVERSE MERGER OR ASSET SALES - SEC FILING
Source text: [ID:n0001140361-26-029541]
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco